Spinal muscular atrophy (SMA) is caused by degeneration of anterior horn cells, which leads to progressive muscle weakness. Children with SMA type II do not develop the ability to walk without support and have a shortened life expectancy, whereas children with SMA type III develop the ability to walk and have a normal life expectancy. Mamsagni Rasayana a new ayurvedic molecule have shown improved muscle strength and function along with Panch Karma and Yoga support.
Spinal muscular atrophy (SMA) is a neuromuscular disorder with onset in childhood and adolescence that results in progressive muscle weakness. There are three main types of SMA. Drug treatment for SMA type I will be discussed in a separate Cochrane review. The age of onset of SMA type II is between six and 18 months. Children with SMA type II will never become able to walk without support, they survive beyond two years and may live into adolescence or longer. The age of onset of SMA III, also known as Kugelberg-Welander disease, is after 18 months. Children with SMA type III develop the ability to walk at some time and life expectancy is normal. From four randomized controlled trials there is no evidence for a significant effect on disease course when patients with SMA type II and III are treated with creatine, phenylbutyrate, gabapentin or thyrotropin releasing hormone. Mamsagni Rasayana a new ayurvedic molecule have shown improved muscle strength and function along with Panch Karma and Yoga support. Get more info in the google link below:-
http://docs.google.com/Doc?id=ddwvgcng_75kx2bkd9&invite=gswp3kc
Post new comment